Rituximab responsive refractory acute graft-versus-host disease

Biol Blood Marrow Transplant. 2006 Nov;12(11):1201-2. doi: 10.1016/j.bbmt.2006.06.013.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Female
  • Graft vs Host Disease / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation / adverse effects
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab